Evaluation Tools and Animal Models of Peripheral Neuropathies

Keywords

Business, Traditional medicine, Medicine, Business administration

References

• Bioluminescence for biological sensing in living mammals.Weisheng Zhang, Pamela R. Contag, Ashima Madan — 1999
• Neurons undergo apoptosis in animal and cell culture models of diabetes.Michael D. Coe — 1999
• Identification of two new Pmp22 mouse mutants using large-scale mutagenesis and a novel rapid mapping strategy.Steffen Walter — 2001
• Suppression of experimental autoimmune neuritis by leflunomide.Ron Acierno, Kenneth J. Ruggiero, Sandro Galea — 2001
• Early Gene Responses of Trophic Factors in Nerve Regeneration Differ in Experimental Type 1 and Type 2 Diabetic Polyneuropathies宏記 笠井, 孝洋 中原, 哲朗 木尾 — 2002
• The novel neurofilament light (NEFL) mutation Glu397Lys is associated with a clinically and morphologically heterogeneous type of Charcot-Marie-Tooth neuropathy.Matthew A. Russell — 2004
• Mycobacterium leprae-induced demyelination: a model for early nerve degeneration.Ilídio Pereira Lopes — 2004
• The numb arm and hand.M D Bracker, L P Ralph — 1995
• Schwann Cell Apoptosis in the Postnatal Axotomized Sciatic Nerve Is Mediated Via NGF through the Low‐Affinity Neurotrophin ReceptorSteven Petratos, Helmut Butzkueven, Kylie Shipham — 2003
• Experimental Rat Models of Types 1 and 2 Diabetes Differ in Sympathetic Neuroaxonal DystrophyRobert E. Schmidt, Denise Dorsey, Lucie N. Beaudet — 2004
• [Cellular aspect of neuroinflammation in Guillain-Barré syndrome: a key to a new therapeutic option?].Alain Créange, Tarek Sharshar, J. C. Raphael — 2002
• Case report: MR findings of Guillain-Barré syndrome.Mitsuru Matsuki, N Okada, Masayuki Matsuo — 1998
• Insulin‐Like Growth Factor‐I and Over‐Expression of Bcl‐xL Prevent Glucose‐Mediated Apoptosis in Schwann CellsCatherine L. Delaney, James W. Russell, Hsin-Lin Cheng — 2001
• Spatial pattern of nerve fiber abnormality indicative of pathologic mechanism.Peter James Dyck, Jeannine L. Karnes, Peter C. O’Brien — 1984
• Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trialsStuart C. Apfel, A. K. Asbury, Vera Bril — 2001
• Carpal tunnel syndrome. MR imaging diagnosis.M Mesgarzadeh, Joseph Triolo, Carson D. Schneck — 1995
• Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiologyRayaz A. Malik, Aristidis Veves, David Walker — 2001
• Hyperglycemia Triggers Abnormal Signaling and Proliferative Responses in Schwann CellsKhaldoun Almhanna, Pamela L. Wilkins, James R. Bavis — 2002
• Hereditary hypertrophic neuropathy in the trembler mouse. Part 2. Histopathological studies: electron microscopy.Phillip A. Low — 1976
• Induction of Postnatal Schwann Cell Death by the Low-Affinity Neurotrophin Receptor In Vitro and after AxotomyDaniel E. Syroid, Peter J. Maycox, Merja Soilu‐Hänninen — 2000

Cited by

• Histopathological and electrophysiological indices of rotenone-evoked dopaminergic toxicity: Neuroprotective effects of acetyl-L-carnitine.Sumit Sarkar, B. Gough, James Raymick — 2015
• Cytoplasmic dynein in neurodegeneration.Judith Eschbach, Luc Dupuis — 2011
• Small Rho GTPases are key regulators of peripheral nerve biology in health and diseaseSven Krause, Claudia Stendel, Jan Senderek — 2008
• Assessment of 3-nitropropionic acid-evoked peripheral neuropathy in rats: neuroprotective effects of acetyl-l-carnitine and resveratrol.Zbigniew Binienda, Micheal A. Beaudoin, B. Gough — 2010
• Mice with a mutation in the dynein heavy chain 1 gene display sensory neuropathy but lack motor neuron disease.Luc Dupuis, Anissa Fergani, Kerstin E. Braunstein — 2009
• Diabetic Peripheral Neuropathies: A Morphometric OverviewValéria Paula Sassoli Fazan, Carlos Augusto Carvalho de Vasconcelos, Marcelo Moraes Valênça — 2010
• Chronic exposure to rotenone, a dopaminergic toxin, results in peripheral neuropathy associated with dopaminergic damage.Zbigniew Binienda, Sumit Sarkar, Lamya Mohammed-Saeed — 2013
• Approach to Creating an Animal Model for Autoimmune Inflammatory PolyneuropathiesWenhui Hu, Jin Jun Luo — 2012
• Effect of dipeptidyl peptidase-IV (DPP-IV) inhibitor (Vildagliptin) on peripheral nerves in streptozotocin-induced diabetic rats.Heung Yong Jin, Wei Jing Liu, Ji Hyun Park — 2009
• Synergistic neroprotective activiity of benfotiamine co administered with erythropoietin in chemotherapy induced peripheral neuropathy in ratsM.G. Hariprasad, Rema Razdan, T.C. Yasha — 2015
• Diabetic Peripheral Neuropathies: A Morphometric Overview Neuropatías Diabéticas Periféricas: Una Visión General MorfométricaValéria Veras de Paula, Sassoli Fazan, Carlos Augusto — 2010
• Use of Nerve Conduction Assessments to Evaluate Drug-Induced Peripheral Neuropathy in Nonclinical Species—A Brief ReviewJamie K. DaSilva, Joseph C. Arezzo — 2020
• Methods for in vivo studies in rodents of chemotherapy induced peripheral neuropathyJordi Bruna, Paola Alberti, Aina Calls — 2019
• Animal models of pain: diversity and benefits.Cynthia Abboud, Alexia Duveau, Rabia Bouali‐Benazzouz — 2020
• Atualização em neuropatias periféricas relacionadas às alterações neurais e vasculares ocorrentes na diabetes mellitus em modelos animaisRonald Rodrigues Guimarães, Osvaldo J. M. Nascimento, José Augusto Coupey Quintanilha — 2009

Related papers

No related papers recorded.